These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 37977814)

  • 1. Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.
    Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):273-300. PubMed ID: 37977814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam.
    Chuang SH; Reddy DS
    J Pharmacol Exp Ther; 2020 Mar; 372(3):285-298. PubMed ID: 31843812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotectant Activity of Novel Water-Soluble Synthetic Neurosteroids on Organophosphate Intoxication and Status Epilepticus-Induced Long-Term Neurological Dysfunction, Neurodegeneration, and Neuroinflammation.
    Reddy DS; Singh T; Ramakrishnan S; Huber M; Wu X
    J Pharmacol Exp Ther; 2024 Jan; 388(2):399-415. PubMed ID: 38071567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based novel antidotes for organophosphate neurotoxicity.
    Reddy DS
    Curr Opin Toxicol; 2019 Apr; 14():35-45. PubMed ID: 32856007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Activity of Novel Hydrophilic Synthetic Neurosteroids on Organophosphate Status Epilepticus-induced Chronic Epileptic Seizures, Non-Convulsive Discharges, High-Frequency Oscillations, and Electrographic Ictal Biomarkers.
    Ramakrishnan S; Singh T; Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):386-398. PubMed ID: 38050069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open-label, dose-finding, phase 2 trial.
    Vaitkevicius H; Ramsay RE; Swisher CB; Husain AM; Aimetti A; Gasior M
    Epilepsia; 2022 Sep; 63(9):2381-2391. PubMed ID: 35748707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors.
    Niquet J; Nguyen D; de Araujo Furtado M; Lumley L
    Epilepsia Open; 2023 May; 8 Suppl 1(Suppl 1):S117-S140. PubMed ID: 36807554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents.
    Wu X; Kuruba R; Reddy DS
    J Pharmacol Exp Ther; 2018 Nov; 367(2):302-321. PubMed ID: 30115757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early polytherapy for benzodiazepine-refractory status epilepticus.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
    Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital.
    Jackson C; Ardinger C; Winter KM; McDonough JH; McCarren HS
    J Pharmacol Toxicol Methods; 2019; 97():1-12. PubMed ID: 30790623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.
    Nguyen DA; Stone MF; Schultz CR; de Araujo Furtado M; Niquet J; Wasterlain CG; Lumley LA
    J Pharmacol Exp Ther; 2024 Jan; 388(2):376-385. PubMed ID: 37770198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurosteroids for the potential protection of humans against organophosphate toxicity.
    Reddy DS
    Ann N Y Acad Sci; 2016 Aug; 1378(1):25-32. PubMed ID: 27450921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.
    Golub V; Ramakrishnan S; Reddy DS
    Exp Neurol; 2023 Feb; 360():114294. PubMed ID: 36493860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGE-102: a novel therapy for refractory status epilepticus.
    Reddy K; Reife R; Cole AJ
    Epilepsia; 2013 Sep; 54 Suppl 6():81-3. PubMed ID: 24001082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication.
    Kuruba R; Wu X; Reddy DS
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2845-2858. PubMed ID: 29802961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy.
    Lattanzi S; Riva A; Striano P
    Expert Rev Neurother; 2021 Nov; 21(11):1317-1332. PubMed ID: 33724128
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing Long-Term Brain Damage by Nerve Agent-Induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but Not by Midazolam Treatment.
    De Araujo Furtado M; Aroniadou-Anderjaska V; Figueiredo TH; Pidoplichko VI; Apland JP; Rossetti K; Braga MFM
    J Pharmacol Exp Ther; 2024 Jan; 388(2):432-450. PubMed ID: 37739807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal.
    Reddy SD; Reddy DS
    Epilepsia; 2015 Jun; 56(6):813-21. PubMed ID: 26032507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Organophosphate Model of Benzodiazepine-Refractory Status Epilepticus and Neuronal Damage.
    Singh T; Ramakrishnan S; Wu X; Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):313-324. PubMed ID: 37770202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.